You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers

 

Online download statistics by month:

Online download statistics by month: May 2021 to July 2025

AbstractFullPdf
May 2021841841334
Jun 2021294294108
Jul 2021249249120
Aug 202119819783
Sep 202117617685
Oct 2021152152101
Nov 202115715672
Dec 202113813952
Jan 20229910747
Feb 2022858745
Mar 202211412159
Apr 202211411952
May 202210611260
Jun 202210511244
Jul 2022859050
Aug 2022727744
Sep 2022818264
Oct 2022778041
Nov 2022676733
Dec 2022616338
Jan 2023717136
Feb 2023939343
Mar 2023989951
Apr 2023373724
May 2023545427
Jun 2023515226
Jul 2023393925
Aug 2023737317
Sep 2023363620
Oct 2023383819
Nov 2023383928
Dec 2023323224
Jan 2024323318
Feb 2024464630
Mar 2024939367
Apr 2024515134
May 2024444431
Jun 2024353422
Jul 2024596032
Aug 2024333213
Sep 2024424231
Oct 2024404026
Nov 2024313213
Dec 2024666725
Jan 2025424222
Feb 2025393923
Mar 2025656649
Apr 2025616227
May 2025686955
Jun 2025464724
Jul 2025110
Total482548842414